FBP1 has two major mechanisms that inhibit ccRCC progression: first, FBP1 can inhibit a potential Warburg effect; second, FBP1 can interact with the HIF inhibitory domain and inhibit nuclear HIF function (40). This evidence concerns the gene FBP1 and nonpapillary renal cell carcinoma.